University of Tokyo, Astellas Enter Second Phase of Strategic Partnership for Co-creation of Innovative New Medicines and Medical Solutions

/PRNewswire/ -- The University of Tokyo (President: Teruo Fujii, Ph.D.) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D.;...

Related Keywords

Japan ,Tokyo ,Ungil Chung ,Kenji Yasukawa ,Yoshitsugu Shitaka ,Teruo Fujii ,Hidenori Ichijo ,University Of Tokyo Center ,School Of Medicine ,Steering Committee ,Astellas Alliance Acceleration Program ,School Of Pharmaceutical Sciences ,School Of Engineering ,Astellas Pharma Inc ,Institute For Life Science Research ,University Of Tokyo ,Astellas Pharma ,Life Science Research ,Tokyo Center ,Graduate School ,Pharmaceutical Sciences ,Yuichi Tei ,Chief Scientific Officer ,Focus Area Approach ,